Marijuana industry reps try to sell state lawmakers on process to help reduce testing costs in Oklahoma
Marijuana Industry NewsMedical MarijuanaOklahoma October 26, 2021 MJ Shareholders 0
Cannabis industry representatives told Oklahoma lawmakers during an interim study Monday that adopting standard practices used by food and drug makers could make medical marijuana cheaper and safer.
They tried to sell lawmakers on process validation, a system where data is collected at different stages of manufacturing to ensure safety. Apothecary Farms and Apothecary Extracts Director of Compliance and Regulatory Affairs Kevin Gallagher explained how it might work for growers, who currently must test every batch for banned pesticides.
“If we’re testing our agricultural chemicals and ensuring that those pesticides don’t reside there originally, why should we have to test every single batch for pesticides, right? The pesticide contamination doesn’t come out of nowhere, right? It has to be in those agricultural chemicals,” Gallagher said.
Gallagher said currently, required testing makes up 48% of growers’ operation costs. He said testing accounts for 5% to 10% of food and drug manufacturers’ costs.
“That’s money that we can reinvest into our employees, our business, our community, and we’re able to make our product cheaper so it can compete within the marketplace,” Gallagher said.
If process validation were approved, the Oklahoma Medical Marijuana Authority would need to develop new standards for it. OMMA Director of Laboratory Oversight Lee Rhoades said the state’s more successful labs are already doing a form of process validation by helping their clients figure out problems. [Read more at Public Radio Tulsa]
MJ Shareholders
MJShareholders.com is the largest dedicated financial network and leading corporate communications firm serving the legal cannabis industry. Our network aims to connect public marijuana companies with these focused cannabis audiences across the US and Canada that are critical for growth: Short and long term cannabis investors Active funding sources Mainstream media Business leaders Cannabis consumers
No comments so far.
Be first to leave comment below.